Express News | Reported Sunday, Bausch Health To Present Key Findings On Xifaxan's Impact On Hepatic Encephalopathy At ACG Annual Meeting
ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (Rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence
Earnings Preview: BHC to Report Financial Results Post-market on October 30
RBC Capital Maintains Bausch Health(BHC.US) With Hold Rating, Raises Target Price to $10
Express News | Bausch Health Companies Inc : RBC Raises Target Price to $10 From $8.5
Bausch Health Price Target Raised to $10 From $8.50 at RBC Capital
Bausch Health (BHC) Reports Next Week: What to Expect
RBC Previews Bausch + Lomb's Q3
Express News | 'Banks, Private Credit Vie for $5 Billion Bausch + Lomb Financing' - Bloomberg
Non-Invasive Aesthetic Treatment Industry Report 2024, Featuring Profiles of Alma Lasers, Bausch Health Companies, Candela, Cutera, Cynosure Lutronic, Daeyang Medical, Fotona, Galderma and More
Toronto Stocks Advance; Canadian Gold Producers Rise on Record Gold Price
Bausch Health Call Volume Above Normal and Directionally Bullish
Stocks to Watch: Netflix, MGP Ingredients, Bausch Health
Bausch Health Turns Down Bondholders' Debt Proposals, WSJ Reports
Bausch Health and Bausch + Lomb Brief: Several Other PE Shops That Had Been Considering an Offer Have Dropped Out, According to the Financial Times Report
Bausch Health and Bausch + Lomb Brief: BHC Up 6% and BLCO Up 8.5% Amid Reports of Private Equity Interest In BLCO, Notes BNN TV
Evercore Maintains Bausch Health(BHC.US) With Hold Rating
Evercore ISI Reaffirms Their Hold Rating on Bausch Health Companies (BHC)
Canadian Stock Movers for Tuesday | Bausch Health Companies Inc Was the Top Gainer; Medical Devices & Instruments Led Gains
Bausch & Lomb Gains Amid Report TPG, Blackstone Working on Joint Bid